The White House said today that it may take enforced ownership of patents on medicines developed with public funding if their manufacturers set their prices too high.
The financial regulator in the US has sent letters to 10 companies that it claims have improperly listed patents in the FDA’s ‘Orange Book’ in order to block generic rival
The capabilities of smartwatches are still very much evolving, and in recent years thoughts have turned to the possibility of using them as medical devices.
The financial regulator in the US has warned the pharma industry that it may consider legal action against companies that improperly list patents in the FDA's 'Orange Book